Biotech companies Biogen Idec ( BIIB.O ) and Gilead Sciences Inc ( GILD.O ) also touched 52-week lows, as did medical device makers such as Boston Scientific Corp ( BSX.N ) and Medtronic ( MDT.N ). Les Funtleyder, a healthcare analyst with Miller Tabak & Co, said he was at a loss to explain why Johnson & Johnson shares fell as much as 9.6 percent during the day.

-----

The drug was linked to less serious bleeding but more deaths due to hemorrhage in an initial analysis. An FDA advisory panel last month recommended the drug stay on the market despite its risks but urged the company to conduct a randomly-controlled clinical trial, a rigorous study that is considered the gold standard for evaluating a drug.

-----

"The sooner it is tempered, the less economic damage will be incurred due to failed expectations," survey director Richard Curtin said in a statement. Consumers also felt better about their personal finances, with 37 percent reporting a worsening financial situation, down from 40 percent as Americans continued to whittle down their debt.

-----

Posen welcomed the 'funding for lending' scheme announced by King and finance minister George Osborne last month. "It is progress," he told reporters after his speech. Posen also said he was pleased that opposition leader Ed Miliband, in a speech earlier on Monday, appeared to have embraced a plan to securitize loans to small businesses that he had suggested almost a year earlier.

-----

FRANKFURT  (Reuters) - The European Central Bank raised interest rates for the first time in more than a year on Thursday, in a widely expected quarter percentage-point move which took benchmark rates to 4.25 percent, the highest level since September 2001.The ECB acted after euro zone inflation accelerated to 4.0 percent year-on-year last month, more than double the bank's medium-term goal.
